Burnie Academy Academy
Metformin for weight loss: honest, modest, and off-label

Metformin for weight loss: honest, modest, and off-label

Metformin is a safe, cheap, well-studied medicine for type 2 diabetes and PCOS, and in diabetes trials it tends to cause slight weight loss rather than weight gain. But in people who do not have diabetes or PCOS, the weight loss from metformin is small and variable, only a few kg over months, and it is not approved as a weight-loss drug. It should not be expected to do what GLP-1 obesity medicines do. Talk to your doctor before using it for weight.

13 Jul 2026 · Burnie Academy
metformin weight-loss diabetes pcos

Metformin is one of the most common and cheapest medicines in India. Doctors give it for type 2 diabetes and for PCOS, and many people take it for years safely. Because some people on metformin lose a little weight, a common hope grows: maybe this cheap tablet can help me lose weight too, even without diabetes. This guide gives you the honest picture. The short version is that metformin can cause a small, variable weight loss in people without diabetes, but it is not a primary weight-loss medicine, it is not approved for obesity, and it should not be expected to match what the newer GLP-1 obesity drugs do. Taking metformin just for weight loss, when you do not have diabetes or PCOS, is off-label, meaning outside the approved use. Please talk to your doctor before any decision.

The baseline: what metformin is and what it is approved for

Metformin belongs to a drug class called biguanide. On the official US medicine label, metformin hydrochloride tablets are described as a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. So its approved job is blood sugar control in type 2 diabetes, not weight loss. It is also widely used for PCOS, another common reason doctors prescribe it in India. How it may affect weight: it lowers the amount of glucose your liver puts out, improves how your body responds to insulin, and may modestly reduce appetite. An important point is that in diabetes trials, metformin tends to cause slight weight loss, unlike some older diabetes medicines such as sulfonylureas or insulin, which often cause weight gain. This is why people hoped it could be a weight-loss pill. But the approved use stays blood sugar control in type 2 diabetes, and using it only for weight in a non-diabetic is off-label.

Metformin in prediabetes (Diabetes Prevention Program)
In the landmark Diabetes Prevention Program, people with prediabetes took metformin for about 2.8 years. Metformin reduced the chance of developing type 2 diabetes by 31 percent compared with placebo, while a lifestyle change reduced it by 58 percent and was significantly more effective than metformin. Average weight loss was 0.1 kg on placebo, 2.1 kg on metformin, and 5.6 kg with lifestyle. So metformin helped prevent diabetes and produced a small real weight loss, but lifestyle beat it, and the weight loss was modest.
Metformin in non-diabetic people with obesity
In people without diabetes, the weight effect is smaller and more variable. A meta-analysis of studies in people with simple obesity found metformin gave about 2.33 kg more weight loss than placebo, with a BMI drop of about 0.57 kg/m2. This is a real but modest effect, far below what is usually called a primary weight-loss result, and it is not an approved use.
GLP-1 receptor agonist (for example, semaglutide / Wegovy)
Semaglutide (Wegovy) is a glucagon-like peptide-1 (GLP-1) receptor agonist that is actually indicated, with a reduced calorie diet and more activity, to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity. So unlike metformin, this class is formally approved for weight management, and the weight loss it produces in trials is much larger than metformin's few kg. This is why GLP-1 drugs, not metformin, are the prescription weight-loss medicines.

Metformin is a great weight-loss pill for everyone.

false

False. Metformin is a safe, cheap, well-studied medicine for type 2 diabetes and PCOS, and in diabetes trials it tends to cause slight weight loss rather than weight gain. But in people without diabetes or PCOS, the weight loss is small and variable, only a few kg over months. A meta-analysis in people with simple obesity found about 2.33 kg more weight loss than placebo, with a BMI drop of about 0.57 kg/m2. In the Diabetes Prevention Program, metformin gave 2.1 kg average weight loss over about 2.8 years, far less than the 5.6 kg from lifestyle change. Metformin is not approved as a weight-loss or obesity drug; the GLP-1 receptor agonist semaglutide (Wegovy) is the one actually indicated to reduce excess body weight and maintain weight reduction long term in adults with obesity. So metformin is not a great weight-loss pill for everyone. Using it just for weight without diabetes or PCOS is off-label and should be decided with a doctor, not on your own.

If your doctor does start metformin, here is the honest safety list

  • Take it with food. The most common problems are stomach ones, nausea, diarrhoea, bloating, and a metallic taste, and they usually settle over time. Taking metformin with meals helps, and an extended-release form can be easier on the stomach if your doctor agrees.
  • Check your kidney function with your doctor. Metformin is cleared by the kidneys, and the label lists severe renal impairment and acute or chronic metabolic acidosis as reasons not to take it. Your doctor checks this before and during treatment.
  • Do not take it in dehydration, severe infection, or very low blood oxygen situations. The official label warns of a rare but serious problem called lactic acidosis, which has on rare occasions led to death, low body temperature, low blood pressure, and resistant slow abnormal heart rhythms, mainly in people with kidney, liver, or heart failure problems.
  • Watch vitamin B12 if used long-term. Long-term metformin use is linked to lower B12 levels, and a review found a mean B12 reduction of about 57 pmol/L, so it is prudent to monitor B12 levels in people at increased risk of deficiency. Ask your doctor about a periodic B12 check.
  • Do not take metformin just for weight without a real reason. In people without diabetes or PCOS, using it for weight is off-label, and the weight effect is only a few kg. Talk to your doctor about whether diet, activity, or a properly approved weight-loss medicine fits you better.
  • Tell your doctor about all your medicines and conditions. Kidney, liver, and heart failure status change whether metformin is safe for you, and the decision belongs with your doctor, not an online tip.

The bottom line

Metformin is a safe, cheap, well-studied medicine for type 2 diabetes and PCOS, and in diabetes trials it tends to cause slight weight loss rather than weight gain. But as a pure weight-loss tool in people without diabetes or PCOS, the effect is small and variable, only a few kg over months, and it is not approved for obesity. In the Diabetes Prevention Program it gave 2.1 kg average weight loss over about 2.8 years, far less than the 5.6 kg from lifestyle change, and a meta-analysis in non-diabetic obesity found about 2.33 kg more weight loss than placebo. The medicines actually approved for weight management are different, such as the GLP-1 receptor agonist semaglutide (Wegovy), which is indicated to reduce excess body weight long term in adults with obesity. So do not expect metformin to do what GLP-1 drugs do. In India metformin is common and cheap for diabetes and PCOS, but taking it only for weight without those conditions is off-label. Talk to your doctor. Burnie can help you log your food and see your daily calorie deficit, but medicine decisions belong with your doctor.

Track your food the honest way

Burnie helps you see your estimated calorie deficit with familiar Indian foods — no fake precision, no guilt trips.

Get Burnie on the App Store

Android public availability is being expanded.